Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
about
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelinesCatastrophic antiphospholipid syndrome: a clinical reviewSingle center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodiesPlasmapheresis in immune hematology: review of clinical outcome data with respect to evidence-based medicine and clinical experience.Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura?Acute respiratory failure associated with catastrophic antiphospholipid syndrome.Foetal loss, liver necrosis and acute lupus erythematosus in a patient with antiphospholipid antibody syndrome.Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients.Acquired thrombophilia.Thrombotic thrombocytopenic purpura and its diagnosis.Antiphospholipid syndrome: a series of surgical emergencies and the current evidence for its management.Anesthetic implications of the catastrophic antiphospholipid syndrome.Platelets in pulmonary vascular physiology and pathology.Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications.36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature.Management of the antiphospholipid syndromeLiver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic EventsAdrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndrome.Shwartzman phenomenon in a patient with active systemic lupus erythematosus preceding fatal disseminated intravascular coagulation.'Catastrophic' antiphospholipid syndrome.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.A role for transoesophageal echocardiography in the early diagnosis of catastrophic antiphospholipid syndrome.Autoantibodies associated with rheumatic diseases.Antiphospholipid syndrome; its implication in cardiovascular diseases: a review.When You are About to Diagnose Chronic Hemolytic Uremic Syndrome, Please Think More Deep.The lung in the antiphospholipid syndrome.Catastrophic cerebral antiphospholipid syndrome presenting as cerebral infarction with haemorrhagic transformation after sudden withdrawal of warfarin in a patient with primary antiphospholipid syndrome.Rheumatology.Antiphospholipid syndrome: an overview.Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly.Adrenal involvement in the antiphospholipid syndrome.Optimising testing for phospholipid antibodies.Long term outcome of catastrophic antiphospholipid syndrome survivors.Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patientsCatastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases.The respiratory system in connective tissue disorders.Cardiac involvement in the antiphospholipid syndrome.
P2860
Q22255576-B4C4A814-8243-4B5F-A9D7-B54804BA4DE9Q27009935-14A86831-E56F-458D-A9FD-A32D7B078A68Q28199044-4A8EF9F5-A20D-4D9F-8A85-1E95D9B64DF7Q30818670-2EDDEDA0-4068-48FE-B5DC-C81081F7C636Q33330004-0A0888F3-756B-436E-AFCE-4B85EFEBF574Q33333068-583B55C8-F10C-4915-837E-3207F5279BCEQ33338791-938F1017-D55F-4E5F-B25C-963C58627EA7Q33341941-9F06A010-03D6-4290-A4D8-CBF8A6B9934BQ33359257-584B7A9F-0D0A-4126-A090-7E18522966D5Q33364695-7D5933F9-7D9A-48F2-815B-AA5ED2D96007Q33366296-2DF13DA8-939A-4CFC-8F61-9B546F35BBFBQ33371908-F5384F71-F58B-4231-B3EA-7B5F687E60D8Q33372650-0C344324-0857-4A90-9E01-C30942B08F5DQ33404240-ADF1BDAA-0F4A-4F04-B97A-E6A3FB41BF61Q33412407-5100A999-06C8-4C6D-85EB-538F8A4313A1Q33418663-9CC58952-89CD-469A-9EA1-11DD127B8DD5Q33423034-6FA5CBA8-2EDB-426A-8955-CEA0C2A486CAQ33424303-542AF3C7-9C19-45C9-9AA3-D00DBB424BDAQ33431396-D25F8141-7153-4699-ABF2-7F302F3C9CF2Q33826408-66F16258-1C1E-41B1-8C04-B87FEA05EC3DQ33959460-E5A9DB15-E2C5-4915-BC0C-B9E65FA90C69Q34062864-8A100418-3ACD-489F-B2D9-8B5BF8B06ED5Q34122035-9E091D1F-99EA-415D-B9AD-49FFA54368E4Q34129533-4F082CDA-776A-46DD-86E6-B723327EDAE2Q34249566-7A719675-2466-4BEA-B1E6-C2310A33A44BQ34331685-097368C0-B1CB-49E3-8468-9531E6AF2FA4Q34340560-AB98DFB0-E090-402C-8E73-B0B01F8B3DDBQ34519511-E79B003A-AA0A-440C-8C4A-79715C1D9E5FQ34526465-83ECD9FF-1B38-4015-81E5-D105E7AD62C4Q34982135-F11870B4-F1CA-4DB7-AEAE-A65CD6DCDC7FQ35099505-88B8822D-B211-4A31-BB22-29997AFBB967Q35135284-2BA2B0AA-8E4F-45A4-AE50-A40669481B90Q35189305-E255A3C9-1BE3-4AA9-89B6-CF98EBC7F40EQ35399567-414A1331-0AA2-4A5E-875A-F6EEFAC1271EQ35552789-1E6FA87C-4C3C-44C9-AA69-1D0D52604145Q35555909-CD04C708-8954-4263-89DB-337E305EB91AQ35636571-52C471EB-E0CC-4B91-B318-5077DE7CA252Q35953379-A0ECF1C0-9E3E-440A-B60A-7A2B1952D737Q36117547-8BA06F38-CCA0-4352-993E-8858372F9B4DQ36283448-908E4896-3187-49BE-9650-4FB213914E03
P2860
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
@ast
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
@en
type
label
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
@ast
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
@en
prefLabel
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
@ast
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
@en
P2093
P50
P1433
P1476
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
@en
P2093
Burcoglu A
Muñoz-Rodríguez FJ
P304
P356
10.1097/00005792-199805000-00005
P407
P577
1998-05-01T00:00:00Z